Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29241979

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2018 Feb 17
First author
Wang M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2018 Feb 17;391(10121):633-634. doi: 10.1016/S0140-6736(17)33256-7.
    note
    Source null
    related pmid
    29241978
    relationship
    Comment in

Authors and identifiers

  1. name
    Wang M
    type
    Author
  2. name
    Rule S
    type
    Author
  3. name
    Zinzani PL
    type
    Author
  4. name
    Goy A
    type
    Author
  5. name
    Casasnovas O
    type
    Author
  6. name
    Smith SD
    type
    Author
  7. name
    Damaj G
    type
    Author
  8. name
    Doorduijn J
    type
    Author
  9. name
    Lamy T
    type
    Author
  10. name
    Morschhauser F
    type
    Author
  11. name
    Panizo C
    type
    Author
  12. name
    Shah B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wang M
    type
    Author
  2. name
    Rule S
    type
    Author
  3. name
    Zinzani PL
    type
    Author
  4. name
    Goy A
    type
    Author
  5. name
    Casasnovas O
    type
    Author
  6. name
    Smith SD
    type
    Author
  7. name
    Damaj G
    type
    Author
  8. name
    Doorduijn J
    type
    Author
  9. name
    Lamy T
    type
    Author
  10. name
    Morschhauser F
    type
    Author
  11. name
    Panizo C
    type
    Author
  12. name
    Shah B
    type
    Author
bibliography ids
  1. nci-bib-55401592b047dde81fa36e91
book metadata
content sha256
2d4eca1b8198c793810e381cfa1ca55d2caa7afc69177f1b1e2421fda7d2a125
document type
citation
dois
  1. 10.1016/S0140-6736(17)33108-2
electronic publication date
display
2017 Dec 11
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29241979
immutable id
pubmed:29241979@2d4eca1b8198c793810e381cfa1ca55d2caa7afc69177f1b1e2421fda7d2a125
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10121
name
Lancet (London, England)
nlm unique id
2985213R
pages
659-667
volume
391
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2018 Feb 17;391(10121):633-634. doi: 10.1016/S0140-6736(17)33256-7.
    note
    Source null
    related pmid
    29241978
    relationship
    Comment in
outcomes validated
false
pmid
29241979
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
1afd7058268a2c261eedfd667865c8a613fc9f570061f155d290d0b91a12744f
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Feb 17
precision
day
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29241979/
title
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.

Preserved source evidence · Not medical advice